Hampig Raphaël Kourié

ctDNA in the Management of Resectable & Advanced Colorectal Cancer: Current Status and Future Directions

Humaid Al-Shamsi, Saeed Rafii, Syed Hammad Tirmazy, D Mukherji et autres

Humaid O Al-Shamsi,1– 7 Saeed Rafii,6,8 Syed Hammad Hassan Tirmazy,6,9 Deborah Mukherji,10 Ahmad Y Abuhelwa,11,12 Faryal Iqbal,1 Siddig Ibrahim Abdelwahab,13 Hampig Raphael Kourie,14 Maen Abdelrahim15,161Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates; 2Department of Medical Oncology, Dana-Farber Cancer Institute, …

ctDNA in the Management of Resectable & Advanced Colorectal Cancer: Current Status and Future Directions

Humaid Obaid Al-Shamsi, Saeed Rafii, Syed Hammad Tirmazy, Deborah Mukherji et autres

Circulating tumor DNA (ctDNA) is an increasingly important biomarker for molecular residual disease (MRD) after curative-intent treatment of colorectal cancer (CRC), but its prognostic value must be distinguished from proven clinical utility. This structured narrative review synthesizes evidence from PubMed/MEDLINE, Embase, ClinicalTrials.gov, …

us, ae, sa, lb, jo (code pays fourni par la source)

Hepatocellular carcinoma A major challenge in the Arab world: A systematic review

Samah Seif, Celina Doueihy, Gilles Prince, Marianne Matar et autres

lb, qa, Égypte, sa (code pays fourni par la source)

Anti-TIGIT therapies in digestive cancers: from immune evasion to precision immunotherapy

Marianne Matar, Céline Yaghi, Gilles Prince, Houssam El Masri et autres

INTRODUCTION: Immune checkpoint inhibitors, particularly anti-PD-1 and anti-PD-L1 therapies, have transformed cancer treatment, yet their effectiveness in gastrointestinal cancers remains limited due to tumor complexity, immunosuppressive microenvironments, and resistance mechanisms. TIGIT, an emerging immune checkpoint receptor expressed on T cells and natural …

lb, fr (code pays fourni par la source)

When Meningioma Travels: Rare Extracranial Metastasis—Case and Review

Tala A. Najdi, Sami Abi Farraj, Pierre El Sett, Clarisse Kattan et autres

Meningiomas are the most common primary intracranial tumors; extracranial metastases occur in < 1% of cases, most often to the lungs or bone. Hepatic spread is exceptionally rare and is more common in atypical or recurrent disease. A 73-year-old man with a …

lb (code pays fourni par la source)

Prophylactic cranial irradiation in ES-SCLC: The ongoing debate from the past to the immunotherapy Era”

Tala A. Najdi, Antoine I. Richa, Mia Chamieh, Toufic Zeidan et autres

SCLC (Small Cell Lung Cancer) is categorized into two stages: limited-stage (LS-SCLC), where the cancer is confined to a single radiation field, and extensive-stage, where the disease has spread beyond the chest, potentially including the brain. In managing extensive-stage SCLC (ES-SCLC), preventing …

lb, fr (code pays fourni par la source)

Updated incidence of EGFR mutation in Middle Eastern patients with non-small cell lung cancer: a 7-year study in a Lebanese institution

Hampig Raphaël Kourié, Charbel Farhat, Joseph Zouein, Alain Chebly et autres

BACKGROUND: This study aims to update the mutational status of EGFR in non-small cell carcinoma (NSCLC), to analyze the spectrum of mutations found, and describe rare mutations in the Lebanese population. METHODS: In this retrospective study, patients diagnosed with NSCLC between 2016 …

lb, us (code pays fourni par la source)

CAR T cells in chronic lymphocytic leukemia: a long unusual journey?

Khalil Saleh, Hampig Raphaël Kourié, Fadi G. Haddad

fr, lb, us (code pays fourni par la source)

Unicentric retrospective study of gastroenteropancreatic neuroendocrine tumors: Updated epidemiological insights

Christèle Asmar, Raphael Asmar, Maria Al Rachid, Carole Kesrouani et autres

lb (code pays fourni par la source)

The first United Arab Emirates expert consensus recommendations for the diagnosis and management of early and advanced non-small cell lung cancer

Humaid Al Shamsi, Nadia Abdelwahed, Hassan Jaafar, Hassan Ghazal et autres

Lung cancer is the first cause of mortality and the third most common cancer worldwide. In the United Arab Emirates (UAE), lung cancer ranks third in terms of cancer-related mortality and sixth in terms of incidence. In order to strengthen and to …

ae, ca, jp, gb, lb, us, om, ir, Égypte, tr, fr, ch (code pays fourni par la source)

The first United Arab Emirates expert consensus recommendations for the diagnosis and management of early and advanced non-small cell lung cancer

Humaid Al Shamsi, Nadia Abdelwahed, Hassan Jaafar, Hassan Ghazal et autres

Lung cancer is the first cause of mortality and the third most common cancer worldwide. In the United Arab Emirates (UAE), lung cancer ranks third in terms of cancer-related mortality and sixth in terms of incidence. In order to strengthen and to …

The first United Arab Emirates expert consensus recommendations for the diagnosis and management of early and advanced non-small cell lung cancer

Humaid Al Shamsi, Nadia Abdelwahed, Hassan Jaafar, Hassan Ghazal et autres

Lung cancer is the first cause of mortality and the third most common cancer worldwide. In the United Arab Emirates (UAE), lung cancer ranks third in terms of cancer-related mortality and sixth in terms of incidence. In order to strengthen and to …